An early MMR before travel, a sibling on chemotherapy and a pregnant mother
At a Tipat Halav (family health centre) in Jerusalem you are asked to see an 11-month-old infant whose family is travelling in three weeks to a country with a large ongoing measles outbreak; they will also attend a crowded family gathering abroad. The infant has received all routine vaccines to date except MMR, which is scheduled at 12 months. The family's five-year-old child is in maintenance chemotherapy for acute lymphoblastic leukaemia and missed the second MMR dose because of treatment. The mother is seven weeks pregnant and has never had her rubella immunity checked. The parents want "everything done at once" before they fly and ask whether the baby can be vaccinated early, whether the older child can catch up now, and whether the mother should also be vaccinated. The clinic nurse is unsure whether an early MMR would "waste" the dose or whether the vaccine could harm the child on chemotherapy at home.
1. Should the 11-month-old receive MMR now? Explain the trade-off and the implications for the routine schedule.
Read the worked answer
Yes - give MMR now. The routine age of 12 months exists because persisting maternal antibodies blunt seroconversion in younger infants; it is a schedule optimisation, not a safety limit. For an infant aged 6–11 months who is travelling to an area with ongoing measles transmission (or during an outbreak), an early dose is recommended. With three weeks before departure, there is enough time for a response to develop.
It does not count as dose 1 of the routine series. Antibody response at 11 months is less reliable, so this dose is a travel dose: the child still needs a dose at ≥12 months of age, at least 28 days after this one, and then the routine second dose (in Israel, at around 6 years, in first grade). Say this clearly to the parents now - otherwise they will believe the child is fully protected and may decline the 12-month visit.
"Wasted dose?" No. An early dose provides real, immediate protection at exactly the moment the child is at risk, and the revaccination rule simply preserves long-term immunity.
Counselling. MMR is a live vaccine; a low-grade fever and a mild rash at days 5–12 are expected. The family should keep the vaccination record with them when travelling. If the infant were severely immunocompromised the calculus would invert, but this infant is healthy.
2. Can the five-year-old on chemotherapy be vaccinated now, and what does the household need in the meantime?
Read the worked answer
No - not while on chemotherapy. MMR is a live attenuated vaccine and is contraindicated during intensive immunosuppressive therapy, including maintenance treatment for acute lymphoblastic leukaemia. The risk is disseminated vaccine-strain infection, and the response would in any case be unreliable.
Timing after treatment. Live vaccines are typically deferred until immune reconstitution. Common practice is to wait at least 3 months after cessation of chemotherapy and to confirm recovery of lymphocyte subsets and immunoglobulins (protocols differ; after haematopoietic stem cell transplant or anti-B-cell therapy the interval is much longer). The decision belongs to the paediatric oncologist together with the immunisation service, and should be planned in advance rather than discovered at the end of treatment.
What the household can do now - cocooning.
- Vaccinate the infant (above) - the greatest risk to the sibling is wild-type measles brought home, not the vaccine.
- Check that both parents and any other household contacts are immune (documented two doses or positive IgG); vaccinate any who are not.
- Explain that the measles vaccine strain is not transmitted from vaccinees to contacts, unlike varicella and rotavirus vaccines, where secondary transmission has been documented - so the infant's vaccination is safe for the sibling.
- If the sibling is exposed to a confirmed measles case, post-exposure prophylaxis is time-critical: MMR within 72 hours if not contraindicated, otherwise immunoglobulin (usually within 6 days), decided with the oncologist.
- During travel, minimise crowded indoor exposure for the whole family.
3. What do you advise for the pregnant mother, and how do you handle the family's request to "do everything at once"?
Read the worked answer
Do not vaccinate her now. MMR is contraindicated in pregnancy on theoretical grounds, chiefly the rubella component; no case of congenital rubella syndrome has been attributed to the vaccine, and inadvertent administration in pregnancy is not an indication for termination. Advise her accordingly if she is anxious about the possibility.
What she does need: documentation of rubella and measles IgG. If she is non-immune, plan MMR immediately postpartum (and before any subsequent pregnancy), and note that she should avoid a further pregnancy for about 4 weeks after vaccination. Measles in pregnancy increases the risk of pneumonia, hospitalisation and preterm delivery, so avoidance is the main tool available right now.
Handling "everything at once". Separate the requests and answer each, because the bundle is what makes the family anxious:
- Infant: yes, today, plus a planned 12-month dose.
- Five-year-old: no, planned with the oncologist.
- Mother: not now, immunity checked now, vaccination after delivery.
Then give the travel advice that carries the most weight: measles is airborne and highly transmissible, so crowded indoor gatherings abroad are the highest-risk setting for an unimmunised or partially immunised household. Encourage hand-carried vaccination records, a pre-travel check 2–3 weeks before departure, and clear instructions to seek care and isolate if fever and rash appear after return.